CURB-65 — pneumonia severity
Stratifies severity of community-acquired pneumonia to guide site-of-care and antibiotic decisions (NICE NG250).
CURB-65 score
0
Low risk — consider ambulatory/home treatment
- 30-day mortality (derivation cohort)
- 0.6%
Caveats & limitations
- A severity aid, not a rule — clinical judgement, social factors, oxygenation and comorbidity also drive admission decisions.
- Mortality figures are from the derivation cohorts; absolute rates vary by setting and era.
- Does not apply to hospital-acquired pneumonia or children.
Evidence & UK guidance
Primary evidence
Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377–382.
UK practice
NICE NG250 recommends CURB-65 in hospital (CRB65 in the community) to stratify CAP severity: low severity (0–1) is suitable for home treatment with oral amoxicillin; moderate (2) and high (3–5) severity drive admission and broader antibiotic choices.
Official resources
Formula and citations last verified: 2026-08-03